Interim Condensed Consolidated Statements of Changes in Equity (unaudited) - CAD ($) $ in Millions |
Total |
Common shares [member] |
Issued capital [member]
Preferred shares and other equity instruments [member]
|
Issued capital [member]
Common shares [member]
|
Treasury instruments [member]
Preferred shares and other equity instruments [member]
|
Treasury instruments [member]
Common shares [member]
|
Retained earnings [member] |
Other components of equity [member] |
Equity attributable to shareholders [member] |
Non-controlling interests [member] |
FVOCI securities and loans [member]
Other components of equity [member]
|
Foreign currency translation reserve [member]
Other components of equity [member]
|
Cash flow hedge reserve [member]
Other components of equity [member]
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balance at beginning of period at Oct. 31, 2024 | $ 127,192 | $ 9,020 | $ 21,013 | $ 11 | $ (61) | $ 88,608 | $ 8,498 | $ 127,089 | $ 103 | $ (897) | $ 7,128 | $ 2,267 | |
| Changes in equity | |||||||||||||
| Issues of share capital and other equity instruments | 1,422 | 1,396 | 36 | (10) | 1,422 | ||||||||
| Common shares purchased for cancellation | (826) | $ (74) | (74) | (752) | (826) | ||||||||
| Sales of treasury shares and other equity instruments | 4,138 | 1,231 | 2,907 | 4,138 | |||||||||
| Purchases of treasury shares and other equity instruments | (4,296) | (1,295) | (3,001) | (4,296) | |||||||||
| Share-based compensation awards | 19 | 36 | 19 | 19 | |||||||||
| Dividends on common shares | (4,179) | (4,179) | (4,179) | ||||||||||
| Dividends on preferred shares and distributions on other equity instruments | (256) | (230) | (230) | (26) | |||||||||
| Other | (33) | (33) | (33) | ||||||||||
| Net income | 9,521 | 9,515 | 9,515 | 6 | |||||||||
| Total other comprehensive income (loss), net of taxes | (172) | 50 | (222) | (172) | (123) | (333) | 234 | ||||||
| Balance at end of period at Apr. 30, 2025 | 132,530 | 10,416 | 20,975 | (53) | (155) | 92,988 | 8,276 | 132,447 | 83 | (1,020) | 6,795 | 2,501 | |
| Balance at beginning of period at Jan. 31, 2025 | 133,263 | 10,416 | 21,006 | (12) | (83) | 90,754 | 11,086 | 133,167 | 96 | (776) | 9,086 | 2,776 | |
| Changes in equity | |||||||||||||
| Issues of share capital and other equity instruments | 14 | 14 | 14 | ||||||||||
| Common shares purchased for cancellation | (488) | (45) | (45) | (443) | (488) | ||||||||
| Sales of treasury shares and other equity instruments | 2,034 | 721 | 1,313 | 2,034 | |||||||||
| Purchases of treasury shares and other equity instruments | (2,147) | (762) | (1,385) | (2,147) | |||||||||
| Share-based compensation awards | 6 | 14 | 6 | 6 | |||||||||
| Dividends on common shares | (2,087) | (2,087) | (2,087) | ||||||||||
| Dividends on preferred shares and distributions on other equity instruments | (124) | (112) | (112) | (12) | |||||||||
| Other | (22) | (22) | (22) | ||||||||||
| Net income | 4,390 | 4,386 | 4,386 | 4 | |||||||||
| Total other comprehensive income (loss), net of taxes | (2,309) | 506 | (2,810) | (2,304) | (5) | (244) | (2,291) | (275) | |||||
| Balance at end of period at Apr. 30, 2025 | 132,530 | 10,416 | 20,975 | (53) | (155) | 92,988 | 8,276 | 132,447 | 83 | (1,020) | 6,795 | 2,501 | |
| Balance at beginning of period at Oct. 31, 2025 | 139,151 | 11,643 | 20,863 | 32 | (110) | 96,938 | 9,726 | 139,092 | 59 | (265) | 7,613 | 2,378 | |
| Changes in equity | |||||||||||||
| Issues of share capital and other equity instruments | 1,426 | 1,361 | 70 | (5) | 1,426 | ||||||||
| Common shares purchased for cancellation | (2,633) | (173) | (173) | (2,460) | (2,633) | ||||||||
| Redemption of preferred shares and other equity instruments | (1,850) | (1,850) | (1,850) | ||||||||||
| Sales of treasury shares and other equity instruments | 6,027 | 2,080 | 3,947 | 6,027 | |||||||||
| Purchases of treasury shares and other equity instruments | (6,086) | (2,128) | (3,958) | (6,086) | |||||||||
| Share-based compensation awards | (69) | 70 | (69) | (69) | |||||||||
| Dividends on common shares | (4,571) | (4,571) | (4,571) | ||||||||||
| Dividends on preferred shares and distributions on other equity instruments | (280) | (276) | (276) | (4) | |||||||||
| Other | (42) | (42) | (42) | ||||||||||
| Net income | 11,294 | 11,291 | 11,291 | 3 | |||||||||
| Total other comprehensive income (loss), net of taxes | (1,594) | 437 | (2,029) | (1,592) | (2) | 60 | (1,425) | (664) | |||||
| Balance at end of period at Apr. 30, 2026 | 140,773 | 11,154 | 20,760 | (16) | (121) | 101,243 | 7,697 | 140,717 | 56 | (205) | 6,188 | 1,714 | |
| Balance at beginning of period at Jan. 31, 2026 | 139,858 | 11,154 | 20,844 | (23) | (8) | 99,265 | 8,569 | 139,801 | 57 | 44 | 6,353 | 2,172 | |
| Changes in equity | |||||||||||||
| Issues of share capital and other equity instruments | 31 | 26 | 5 | 31 | |||||||||
| Common shares purchased for cancellation | (1,673) | (110) | (110) | (1,563) | (1,673) | ||||||||
| Sales of treasury shares and other equity instruments | 3,211 | 1,268 | 1,943 | 3,211 | |||||||||
| Purchases of treasury shares and other equity instruments | (3,317) | (1,261) | (2,056) | (3,317) | |||||||||
| Share-based compensation awards | 3 | $ 26 | 3 | 3 | |||||||||
| Dividends on common shares | (2,279) | (2,279) | (2,279) | ||||||||||
| Dividends on preferred shares and distributions on other equity instruments | (138) | (135) | (135) | (3) | |||||||||
| Other | (10) | (10) | (10) | ||||||||||
| Net income | 5,509 | 5,507 | 5,507 | 2 | |||||||||
| Total other comprehensive income (loss), net of taxes | (422) | 450 | (872) | (422) | (249) | (165) | (458) | ||||||
| Balance at end of period at Apr. 30, 2026 | $ 140,773 | $ 11,154 | $ 20,760 | $ (16) | $ (121) | $ 101,243 | $ 7,697 | $ 140,717 | $ 56 | $ (205) | $ 6,188 | $ 1,714 |